Attached files
| file | filename |
|---|---|
| EX-99.1 - GENTA INC DE/ | v173778_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported): February 10,
2010
GENTA
INCORPORATED
(Exact
Name of Registrant
as
Specified in Its Charter)
Delaware
(State or
Other Jurisdiction of Incorporation)
|
0-19635
|
33-0326866
|
|
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
|
200
Connell Drive
Berkeley
Heights, NJ
|
07922
|
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
|
(908)
286-9800
(Registrant’s
Telephone Number, Including Area Code)
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the Registrant under any
of the following provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a
-12)
|
|
¨
|
Pre
-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d -2(b))
|
|
¨
|
Pre
-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Events.
On
February 10, 2010, Genta Incorporated, (the Company), announced that it has
received $2.8 million in non-dilutive cash proceeds from the sale of net
operating tax losses and research tax credits generated in prior tax years as
part of the Technology Business Tax Certificate Program sponsored by the New
Jersey Economic Development Authority (NJEDA), pursuant to the rules,
regulations and stipulations set forth by the program. This program,
which focuses on biotechnology and other research-based companies, is designed
to attract and retain knowledge-intensive businesses that will enhance the
State’s strategic and competitive interests in these areas.
Genta
also announced that the Company’s request for designation as a Small-to-Medium
Sized Enterprise (SME) had been granted by the European Medicines Agency
(EMEA). SME status provides certain financial and administrative
assistance to small businesses as they advance their regulatory filings and
submissions through the EMEA.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
|
Exhibit
Number
|
Description
|
|
|
99.1
|
|
Press
Release of the Company dated February 10,
2010
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
GENTA
INCORPORATED
|
|||||
|
Date:
|
February
10, 2010
|
By:
|
/s/
GARY SIEGEL
|
||
|
Name:
|
Gary
Siegel
|
||||
|
Title:
|
Vice
President,
Finance
|
||||
EXHIBIT
INDEX
|
Exhibit
Number
|
Description
|
Sequentially
Numbered Page
|
||
|
99.1
|
|
Press
Release of the Company dated February 10, 2010
|
|